絞り込み

16598

広告

「denosumab」の検索結果

2575件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.

Evaluation of appropriate use of bisphosphonates and denosumab in patients with cancer.

[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]

[Bone effects of bisphosphonates and denosumab treatments in breast or prostate cancer].

Effects of denosumab on hypercalcemia and bone mineral density loss in kidney transplant recipients
.

The RANKL-RANK Axis: A Bone to Thymus Round Trip.

Denosumab Therapy in the Management of Aneurysmal Bone Cysts: A Comprehensive Literature Review.

Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study.

A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy.

Drug efficacies on bone mineral density and fracture rate for the treatment of postmenopausal osteoporosis: a network meta-analysis.

Resolution of a case of denosumab-related osteonecrosis of the jaw after tooth extraction.

The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment.

Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss.

Complications Encountered with Non-adherence to Regular Follow-up in the Long-term Medical Management of Hyperparathyroidism.

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.

Stress fractures in systemic lupus erythematosus after long-term MTX use successfully treated by MTX discontinuation and individualized bone-specific therapy.

The utilization and challenges of Japan's MID-NET medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies.

Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases.

Ultrasonic Piezoelectric Bone Surgery Combined with L-PRF and Pedicled Buccal Fat Pad Flap in Denosumab-Related Osteonecrosis of the Jaw.

Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります